Table 3.
Summary of baseline characteristics by ABC adherence status for the selected studies
| First author (year) | Grouped and overall | N (%) | Age, mean ± SD or median (IQR) | Women (%) | Hypertension (%) | CHA2DS2-VASc, mean ± SD or median (IQR) |
|---|---|---|---|---|---|---|
| Prospective | ||||||
| Domek (2020)15 | ABC | 86 (14.3%) | 64.8 ± 10.8 | 44 (51.2%) | 69 (80.2%) | 3.60 ± 1.27 |
| Non-ABC | 517 (85.7%) | 63.2 ± 11.9 | 271 (52.4%) | 421 (81.4%) | 3.70 ± 1.63 | |
| All | 603 | 63.4 ± 11.8 | 315 (52.2%) | 490 (81.3%) | 3.69 ± 1.58 | |
| Gumprecht (2020)16 | ABC | 168 (8.3%) | 64.5 ± 12.0 | 77 (45.7%) | 117 (69.6%) | 3.01 ± 1.53 |
| Non-ABC | 1853 (91.7%) | 56.0 ± 16.7 | 891 (48.1%) | 948 (51.2%) | 2.28 ± 1.79 | |
| All | 2021 | 56.7 ± 16.47 | 968 (47.9%) | 1065 (52.7%) | 2.34 ± 1.78 | |
| Guo (2020) 1 year18 | mAFA | 1646 (49.5%) | 67.0 ± 15.0 | 625 (38.0%) | 908 (55.2%) | 3 (2–4) |
| Usual Care | 1678 (50.5%) | 70.0 ± 12.0 | 637 (38.0%) | 962 (57.3%) | 3 (2–4) | |
| All | 3324 | Not reported | 1262 | 1870 (56.3%) | Not reported | |
| Guo (2020) Extension17 | mAFA | 1261 (51.0%) | 67.8 ± 15.4 | 34.1% | 797 (63.2%) | 3 (2–4) |
| Usual Care | 1212 (49.0%) | 70.1 ± 12.0 | 42.1% | 776 (64.0%) | 3 (2–4) | |
| All | 2473 | Not reported | Not reported | Not reported | Not reported | |
| Koziel (2020)12 | ABC | 1013 (43.8%) | 49 (41–57) | 485 (47.9%) | 898 (88.6%) | 3.4 ± 1.8 |
| Non-ABC | 1299 (56.2%) | 64 (55–71) | 557 (42.9%) | 882 (67.9%) | 3.4 ± 1.9 | |
| All | 2712 | Not reported | Not reported | Not reported | Not reported | |
| Retrospective—post hoc | ||||||
| Proietti (2018, 2020)21,22 | ABC | 222 (7.0%) | 70 (65–75) | 60 (27.0%) | 141 (63.5%) | 3 (2–4) |
| Non-ABC | 2947 (93.0%) | 70 (65–76) | 1177 (39.9%) | 2102 (71.3%) | 2 (1–3) | |
| All | 3169 | 70 (65–76) | 1237 (39.0%) | 2243 (70.8%) | 3 (2–4) | |
| Pastori (2019)19 | ABC | 198 (22.4%) | 71.7 ± 9.0 | 48.2% | 85.6% | 2.56 ± 1.1 |
| Non-ABC | 684 (77.6%) | 73.5 ± 8.3 | 38.7% | 89.3% | 3.7 ± 1.5 | |
| All | 882 | 73.1 ± 8.5 | 40.8% | 88.5% | 3.50 ± 1.5 | |
| Retrospective—registry or electronic health records | ||||||
| Yoon (2019)14 | ABC | 31 674 (15.5%) | 52.9 ± 12.2 | 10 129 (32.0%) | 5708 (18.0%) | 0.91 ± 1.39 |
| Non-ABC | 173 168 (84.5%) | 64.9 ± 10.8 | 66 778 (38.6%) | 139 411 (80.5%) | 2.97 ± 1.80 | |
| All | 204 842 | Not reported | Not reported | Not reported | Not reported | |
| Proietti (2020) ESC-EHRA20 | ABC | 1996 (30.0%) | 70 (61–76) | 741 (37.1%) | 1184 (59.7%) | 2.68 ± 1.57; 3 (2–4) |
| Non-ABC | 4650 (70.0%) | 69 (61–76) | 1926 (41.4%) | 2693 (58.5%) | 3.07 ± 1.90; 3 (2–4) | |
| All | 6646 | Not reported | Not reported | Not reported | Not reported | |
| Yang (2020) dementia23 | ABC | 45 994 (20.2%) | 68.8 ± 10.2 | 18 016 (39.2%) | 2425 (5.3%) | 0 (0–1) |
| Non-ABC | 182 052 (79.8%) | 69.7 ± 11.6 | 70 218 (38.6%) | 117 688 (64.7%) | 2 (1–3) | |
| All | 228 026 | Not reported | Not reported | Not reported | Not reported | |
| Yang (2020) frailty13 | ABC | 49 533 (18.8%) | 50 (41, 58) | 39.4% | 7.0% | 0 (0–1) |
| Non-ABC | 213 454 (81.1%) | 65 (56, 72) | 38.6% | 65.5% | 2 (1–3) | |
| All | 262 987 | Not reported | Not reported | Not reported | Not reported | |
ABC, Atrial Fibrillation Better Care; AF, atrial fibrillation; EHRA, European Heart Rhythm Association; ESC, European Society of Cardiology; mAFA, mobile AF-App.